Journal of Alzheimer's Disease
Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.

TitleMultimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
Publication TypeJournal Article
Year of Publication2016
AuthorsEustache, P, Nemmi, F, Saint-Aubert, L, Pariente, J, Péran, P
JournalJ Alzheimers Dis
Volume50
Issue4
Pagination1035-50
Date Published2016
ISSN1875-8908
KeywordsAged, Alzheimer Disease, Biomarkers, Brain, Cognitive Dysfunction, Diffusion Tensor Imaging, Female, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging, Male, Mental Status Schedule, Multimodal Imaging, Neuropsychological Tests, Organ Size, Positron-Emission Tomography, Prodromal Symptoms, Radiopharmaceuticals
Abstract

One objective of modern neuroimaging is to identify markers that can aid in diagnosis, monitor disease progression, and impact long-term drug analysis. In this study, physiopathological modifications in seven subcortical structures of patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD) were characterized by simultaneously measuring quantitative magnetic resonance parameters that are sensitive to complementary tissue characteristics (e.g., volume atrophy, shape changes, microstructural damage, and iron deposition). Fourteen MCI patients and fourteen matched, healthy subjects underwent 3T-magnetic resonance imaging with whole-brain, T1-weighted, T2*-weighted, and diffusion-tensor imaging scans. Volume, shape, mean R2*, mean diffusivity (MD), and mean fractional anisotropy (FA) in the thalamus, hippocampus, putamen, amygdala, caudate nucleus, pallidum, and accumbens were compared between MCI patients and healthy subjects. Comparisons were then performed using voxel-based analyses of R2*, MD, FA maps, and voxel-based morphometry to determine which subregions showed the greatest difference for each parameter. With respect to the micro- and macro-structural patterns of damage, our results suggest that different and distinct physiopathological processes are present in the prodromal phase of AD. MCI patients had significant atrophy and microstructural changes within their hippocampi and amygdalae, which are known to be affected in the prodromal stage of AD. This suggests that the amygdala is affected in the same, direct physiopathological process as the hippocampus. Conversely, atrophy alone was observed within the thalamus and putamen, which are not directly involved in AD pathogenesis. This latter result may reflect another mechanism, whereby atrophy is linked to indirect physiopathological processes.

DOI10.3233/JAD-150353
Alternate JournalJ. Alzheimers Dis.
PubMed ID26836151
PubMed Central IDPMC4927932
E-mail Icon
Comment Icon
  • Comment
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
  • Comment
| Bookmark | Recommend | Follow

Source URL: https://www.j-alz.com/content/multimodal-magnetic-resonance-imaging-alzheimers-disease-patients-prodromal-stage